Low, Yi Ling <br/><br/>
Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.  [electronic resource] 

 -  Molecular pharmaceutics  03 2020 
 - 873-884 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/acs.molpharmaceut.9b01131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--metabolism<br/>Animals<br/>Blood-Brain Barrier--drug effects<br/>Carbon Radioisotopes--metabolism<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Docosahexaenoic Acids--metabolism<br/>Endothelial Cells--drug effects<br/>Fatty Acid-Binding Proteins--metabolism<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Proteins--metabolism<br/>PPAR gamma--agonists<br/>Pioglitazone--pharmacology<br/>Protein Transport--drug effects<br/>Signal Transduction--drug effects